Stewart & Patten Co. LLC boosted its stake in Colgate-Palmolive (NYSE:CL) by 10.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,859 shares of the company’s stock after purchasing an additional 11,570 shares during the quarter. Colgate-Palmolive comprises approximately 1.6% of Stewart & Patten Co. LLC’s portfolio, making the stock its 27th biggest holding. Stewart & Patten Co. LLC’s holdings in Colgate-Palmolive were worth $8,878,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. OLD Second National Bank of Aurora bought a new position in shares of Colgate-Palmolive in the second quarter worth approximately $109,000. Krilogy Financial LLC grew its holdings in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the last quarter. Harbour Capital Advisors LLC bought a new position in shares of Colgate-Palmolive in the first quarter worth approximately $121,000. Hanson & Doremus Investment Management boosted its holdings in Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares in the last quarter. Finally, Captrust Financial Advisors bought a new stake in Colgate-Palmolive in the second quarter valued at $122,000. 72.83% of the stock is currently owned by institutional investors and hedge funds.
CL has been the topic of several recent analyst reports. Citigroup cut their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Monday, October 23rd. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research report on Tuesday, December 19th. Finally, SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price target for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $76.51.
Shares of Colgate-Palmolive (NYSE:CL) traded up $0.07 during trading hours on Friday, hitting $74.62. The company had a trading volume of 2,338,181 shares, compared to its average volume of 3,030,000. The company has a market cap of $65,520.00, a P/E ratio of 28.81, a PEG ratio of 3.15 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the prior year, the company posted $0.73 EPS. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. research analysts predict that Colgate-Palmolive will post 2.88 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s payout ratio is 61.78%.
In other news, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the sale, the insider now directly owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now directly owns 45,217 shares in the company, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 181,950 shares of company stock valued at $13,237,385 over the last 90 days. 1.02% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.